Elevated Fasting Glucose Predicts Mortality in Patients With CAD

"Patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) who have elevated fasting glucose levels are at increased risk of death, according to the results of a prospective trial published in the August issue of the American Heart Journal. The investigators were surprised by the frequency of undiagnosed diabetes as well as the hazard associated with 'prediabetes,' and the editorialist suggests that these patients be treated as aggressively as patients with diabetes."